UK-based Healios is a telepsychiatry platform that provides digital interventions for young adults and children with a range of mental health conditions and neurodiverse diseases such as anxiety, autism, low mood, and attention deficit hyperactivity disorder. Digital interventions offered via the company’s mobile app, ThinkNinja, include specialist clinical assessments, video-based therapy sessions with in-network clinicians, self-care tools, and tailored support programs. As of 2023, Healios had conducted over 200,000 clinical sessions.
The company adopts a family-centric approach to assessment, therapy, and treatment with the company claiming to have developed the first digital family-focused therapy program for young people with psychosis and schizophrenia. The company has also developed digital biomarker tools, including a smartphone app called DreaMS that monitors neurological functions in multiple sclerosis patients.
Key customers and partnerships
Healios has been collaborating with the NHS for over a decade and as of May 2021, Healios has delivered more than 70,000 sessions for NHS customers.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.